Nav: Home

Let's map our DNA and save billions each year in health costs

January 09, 2019

A UniSA scientist has called for Australia to embrace pharmacogenetic (PGx) testing to deliver medication more effectively and slash around $2.4 billion wasted each year through unsafe and ineffective drug prescriptions.

Dr Vijay Suppiah, a senior lecturer in pharmacy at UniSA, says PGx testing - mapping a person's genetic makeup - is the most effective way to ensure patients are prescribed drugs which suit their specific DNA profile.

"Most people expect that when they get a prescription filled from a pharmacy, it will be effective and have minimal side effects. Unfortunately, that only happens in up to 60 per cent of cases," he says.

"People don't realise their genetic makeup plays a large role in whether a specific drug will work or not, or even have adverse side effects."

In an article published in the Australian Journal of Primary Health, Dr Suppiah says while heavy investment into PGx research is happening in the US and Europe, Australia is lagging far behind.

"This technology exists right now and, internationally, PGx testing is slowly evolving into a specialised area to guide drug selection based on genetic findings. However, in Australia, apart from a selected few medications, such as those in oncology, most other medical specialities are yet to be involved."

A pharmacogenetic analysis by Deloitte Economics Australia suggests that PGx testing would deliver an economic benefit of $12 billion over five years to the national health system if it was widely adopted in Australia.

"It would minimise adverse drug reactions, avoid wastage and improve quality of care for patients by enabling doctors to target the right drug and the correct dose for a patient. Also, PGx testing needs to be performed only once which is unlike blood glucose or blood pressure monitoring where patients have to do repeated testing."

PGx testing could also address issues around polypharmacy, commonly defined as the use of five or more medicines - which raises concerns, particularly for older people.

A 2018 survey of 40 elderly people in Adelaide found that almost 78 per cent used five or more medicines. Only 17 per cent were aware of the potential interactions between their medicines and just over 37 per cent said their GP had not discussed possible side effects of their medications.

"Most participants could not describe the condition for which each medicine was prescribed, which is also very concerning," Dr Suppiah says.

He says pharmacogenetic testing would help clarify the potential impact of drug interactions at the genetic level for different people- an area rife with risks.

A common example involves the interaction of drugs treating depression and pain.

"Some of the anti-depressants prescribed by doctors decrease the effectiveness of opioids to provide pain relief. This would result in these patients seeking out larger doses of opioids for pain relief. By knowing their genetic makeup, community pharmacists would be able to pick up this interaction and suggest alternative pain treatment. Also, patients on multiple drugs have a higher risk of falls because many drugs work centrally in the brain and dull the senses."

People seeing several health practitioners - GPs as well as specialists - are also more likely to have issues with drug interactions if there are communication gaps between health practitioners.

These risks could be curtailed if trained community pharmacists are able to implement pharmacogenetic testing within their community pharmacies, Dr Suppiah says.

"We need to do a lot more research investigating the genetic basis of drug interactions with polypharmacy and this could lead to better tailoring of treatment based on an individual's genetic makeup.

"If community pharmacists had access to their clients' PGx test results in their database, they could tell straight away if a particular drug or dose is going to work optimally for that client based on that individual's genetic makeup."
-end-


University of South Australia

Related Pain Articles:

Pain researchers get a common language to describe pain
Pain researchers around the world have agreed to classify pain in the mouth, jaw and face according to the same system.
It's not just a pain in the head -- facial pain can be a symptom of headaches too
A new study finds that up to 10% of people with headaches also have facial pain.
New opioid speeds up recovery without increasing pain sensitivity or risk of chronic pain
A new type of non-addictive opioid developed by researchers at Tulane University and the Southeast Louisiana Veterans Health Care System accelerates recovery time from pain compared to morphine without increasing pain sensitivity, according to a new study published in the Journal of Neuroinflammation.
The insular cortex processes pain and drives learning from pain
Neuroscientists at EPFL have discovered an area of the brain, the insular cortex, that processes painful experiences and thereby drives learning from aversive events.
Pain, pain go away: new tools improve students' experience of school-based vaccines
Researchers at the University of Toronto and The Hospital for Sick Children (SickKids) have teamed up with educators, public health practitioners and grade seven students in Ontario to develop and implement a new approach to delivering school-based vaccines that improves student experience.
Pain sensitization increases risk of persistent knee pain
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis (OA), according to a new study by researchers from the Université de Montréal (UdeM) School of Rehabilitation and Hôpital Maisonneuve Rosemont Research Centre (CRHMR) in collaboration with researchers at Boston University School of Medicine (BUSM).
Becoming more sensitive to pain increases the risk of knee pain not going away
A new study by researchers in Montreal and Boston looks at the role that pain plays in osteoarthritis, a disease that affects over 300 million adults worldwide.
Pain disruption therapy treats source of chronic back pain
People with treatment-resistant back pain may get significant and lasting relief with dorsal root ganglion (DRG) stimulation therapy, an innovative treatment that short-circuits pain, suggests a study presented at the ANESTHESIOLOGY® 2018 annual meeting.
Sugar pills relieve pain for chronic pain patients
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology.
Peripheral nerve block provides some with long-lasting pain relief for severe facial pain
A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia (TGN) may produce long-term pain relief.
More Pain News and Pain Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.